Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$0.3290
0.013.46%
After Hours: 9:11 AM EDT
Comments
Loading...
FibroGen (FGEN) Forecast
NewsEarningsFibroGen (FGEN) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Edge Members Only
Benzinga Rankings give you vital metrics on any stock – anytime.
FibroGen Stock Price, Quotes and Forecasts | NASDAQ:FGEN | Benzinga
Explore FibroGen stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for FGEN.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy FibroGen (FGEN) stock?
You can purchase shares of FibroGen (NASDAQ:FGEN) through any online brokerage.
Who are FibroGen (FGEN) competitors?
Other companies in FibroGen’s space includes: Kezar Life Sciences (NASDAQ:KZR), Estrella Immunopharma (NASDAQ:ESLA), Imunon (NASDAQ:IMNN), Burning Rock Biotech (NASDAQ:BNR) and Coeptis Therapeutics (NASDAQ:COEP).
What is the forecast, or price target, for FibroGen (FGEN) stock?
FibroGen has a consensus price target of $10.00.
What is the current price for FibroGen (FGEN)?
The stock price for FibroGen (NASDAQ: FGEN) is $0.329 last updated May 29, 2025 at 9:11 AM EDT.
Does FibroGen (FGEN) pay a dividend?
There are no upcoming dividends for FibroGen.
When is FibroGen (NASDAQ:FGEN) reporting earnings?
FibroGen’s Q2 earnings are confirmed for Tuesday, August 5, 2025.
Is FibroGen (FGEN) going to split?
There is no upcoming split for FibroGen.
What sector and industry does FibroGen (FGEN) operate in?
FibroGen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
